Biosyntia
PrivateLast Round
Series B
Extension
Sep 29, 2022
Total Funding Raised
$24.54M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biosyntia operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series B Extension round in September 2022.
Biosyntia is a biotechnology company that develops and produces natural active ingredients, such as vitamins, through sustainable fermentation processes for the nutrition and beauty industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosyntia Comparables
Compare Biosyntia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amyris | 83% | |
| Cellibre | 81% | |
| Conagen | 80% |
For institutional investors. Book with your work email.
Biosyntia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 29, 2022 | ||||
| Series B | Jul 6, 2022 | ||||
| Series A | Apr 24, 2018 | ||||
| Seed | May 21, 2015 | ||||
| Grant | Jun 1, 2013 | ||||
Grant | Jun 1, 2012 |
For institutional investors. Book with your work email.
Biosyntia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Holdings | Series B Extension, Series B, Grant, Series A, Seed |
| Praesidium | Series B Extension |
| The Export and Investment Fund of Denmark | Series B Extension |
| Sofinnova Partners | Series B Extension, Series B, Series A |
| ECBF Management | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 52% MoM, reaching 3K.
- Jun 19, 2026
Monthly visitors increased 179% MoM, reaching 2K.
For institutional investors. Book with your work email.
Biosyntia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biosyntia's valuation, stock price, and market status.
Is Biosyntia a public or private company?
Biosyntia is a private company.
What is the current stock price of Biosyntia?
Biosyntia is a private company, so its shares have no public market price. Caplight tracks Biosyntia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biosyntia worth (valuation)?
Valuation information for Biosyntia is not publicly available.
Can I buy Biosyntia stock?
Biosyntia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biosyntia's last funding round?
Biosyntia's most recent funding round was Series B Extension on September 29, 2022.
Who are the main investors in Biosyntia?
Key investors in Biosyntia include Novo Holdings, Praesidium, ECBF Management.
Will Biosyntia IPO soon?
No public IPO plans have been announced for Biosyntia.
How can I track Biosyntia secondary market activity?
Caplight tracks bids, offers, and trades in Biosyntia's shares on secondary markets.